Evidence map›Paper›PMID 29790007›Full record

ArticleIndian journal of pediatrics2018

Sublingual Immunotherapy Decreases Expression of Interleukin-33 in Children with Allergic Rhinitis.

Yuanming Wang, Chuling Li, Yaxiong Xu, Deyu Xu, Gang Yang, Fang Liao, Xianglin Luo

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Indian journal of pediatrics, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.4field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 23 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Review
  4. Review
  5. Review
  6. Article
  7. [Advances of IL-33/ST2 signaling pathway in allergic rhinitis].Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology head and neck surgery · 2020
    Review
  8. Review
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Yuanming WangDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Chuling LiDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China. chulinglidg@163.com.ORCID http://orcid.org/0000-0002-4878-2123
Yaxiong XuDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Deyu XuDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Gang YangDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Fang LiaoDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Xianglin LuoDepartment of Otolaryngology, Dongguan Women and Children's Hospital, No 99. Zhenxing Road, Dongguan, 523120, China.
Dongguan People’s Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo identify the expression of IL-33 during SLIT (Sublingual immunotherapy) in AR (Allergic rhinitis) children.

methodsThirty children received house dust mite (HDM) allergen extract for SLIT and thirty children received placebo in this study. Serum and nasal lavage samples of cases and controls were collected at different time points during SLIT. Interleukin (IL)-33 and other cytokines were estimated in these samples by enzyme-linked immuno sorbent assay (ELISA). Peripheral blood mononuclear cells (PBMC) were prepared and stimulated with rhIL-33 (with or without other stimulators) at different time points during SLIT.

resultsThe present results showed that both serum and nasal lavage of IL-33 levels decreased significantly after 12 mo treatment and this trend maintained at least until 24 mo. The decreased nasal IL-33 level was positively correlated to local Th2 cytokines and increased IL-10 expression at 2 y post SLIT treatment. In vitro experiments showed that IL-33 promotes IL-4 and IL-5 and inhibits IL-10 expression by peripheral blood mononuclear cells (PBMCs) in AR.

conclusionsDecreased IL-33 expression during SLIT may contribute to low Th2 response and enhanced Regulatory T cell cytokines expression. Thus, IL-33 maybe an important predictor during SLIT.

Indexed as

Sublingual ImmunotherapyAdolescentAnimalsAntigens, DermatophagoidesChildCytokinesFemaleHumansInterleukin-33MaleNasal Lavage FluidProspective StudiesRhinitis, AllergicTh2 CellsAntigens, DermatophagoidesCytokinesIL33 protein, humanInterleukin-33Allergic rhinitisInterleukin 33Sublingual immunotherapyTh2 cytokines

Identifiers

PMID29790007
OpenAlexW2804575300

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.